Scientific Publications

Clinical characterization and ancillary tests in Susac syndrome: a systematic review

A. Wilf-Yarkoni
O. Zmira
A. Tolkovsky
B. Pflantzer
S.G. Gofrit
I. Kleffner
F. Paul
J. Dörr

Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity - a potential diagnostic pitfall in patients with MOG-EM/MOGAD

S. Jarius
M. Ringelstein
K. Schanda
K. Ruprecht
M. Korporal-Kuhnke
A. Viehöver
M.W. Hümmert
P. Schindler
V. Endmayr
M. Gastaldi
C. Trebst
D. Franciotta
O. Aktas
R. Höftberger
J. Haas
L. Komorowski
F. Paul
M. Reindl
B. Wildemann

Time to disability milestones and annualized relapse rates in NMOSD and MOGAD

A. Duchow
J. Bellmann-Strobl
T. Friede
O. Aktas
K. Angstwurm
I. Ayzenberg
A. Berthele
E. Dawin
D. Engels
K. Fischer
M. Flaskamp
K. Giglhuber
M. Grothe
J. Havla
M.W. Hümmert
S. Jarius
M. Kaste
P. Kern
I. Kleiter
L. Klotz
M. Korporal-Kuhnke
M. Kraemer
M. Krumbholz
T. Kümpfel
L. Lohmann
M. Ringelstein
P. Rommer
P. Schindler
C. Schubert
C. Schwake
M. Senel
F.T. Bergh
D. Tkachenko
H. Tumami
C. Trebst
I. Vardakas
A. Walter
C. Warnke
M.S. Weber
J. Wickel
B. Wildemann
A. Winkelmann
F. Paul
J.P. Stellmann
V. Häußler

Body mass, neuro-hormonal stress processing, and disease activity in lean to obese people with multiple sclerosis

L. Meyer-Arndt
J. Brasanac
S. Gamradt
J. Bellmann-Strobl
L. Maurer
K. Mai
T. Steward
J. Spranger
T. Schmitz-Hübsch
F. Paul
S.M. Gold
M. Weygandt

CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis

F. Cortes-Figueiredo
S. Asseyer
C. Chien
H.G. Zimmermann
K. Ruprecht
T. Schmitz-Hübsch
J. Bellmann-Strobl
F. Paul
V.A. Morais

The T1-weighted/T2-weighted ratio as a biomarker of anti-NMDA receptor encephalitis

T.J. Hartung
G. Cooper
V. Jünger
D. Komnenić
L. Ryan
J. Heine
C. Chien
F. Paul
H. Prüss
C. Finke

The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation

O. Golubnitschaja
J. Polivka
P. Potuznik
M. Pesta
I. Stetkarova
A. Mazurakova
L. Lackova
P. Kubatka
M. Kropp
G. Thumann
C. Erb
H. Fröhlich
W. Wang
B. Baban
M. Kapalla
N. Shapira
K. Richter
A. Karabatsiakis
I. Smokovski
L.C. Schmeel
E. Gkika
F. Paul
P. Parini
J. Polivka

Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories

C.C. Gross
A. Schulte-Mecklenbeck
O.V. Steinberg
T. Wirth
S. Lauks
S. Bittner
P. Schindler
S.E. Baranzini
S. Groppa
J. Bellmann-Strobl
N. Bünger
C. Chien
E. Dawin
M. Eveslage
V. Fleischer
G. Gonzalez-Escamilla
B. Gisevius
J. Haas
M. Kerschensteiner
L. Kirstein
C. Korsukewitz
L. Lohmann
J.D. Lünemann
F. Luessi
G. Meyer Zu Hörste
J. Motte
T. Ruck
K. Ruprecht
N. Schwab
F. Steffen
S.G. Meuth
F. Paul
B. Wildemann
T. Kümpfel
R. Gold
T. Hahn
F. Zipp
L. Klotz
H. Wiendl

March 01, 2024 / J Neurol

Predicting disease severity in multiple sclerosis using multimodal data and machine learning

M. Andorra
A. Freire
I. Zubizarreta
N.K. de Rosbo
S.D. Bos
M. Rinas
E.A. Høgestøl
S.A. de Rodez Benavent
T. Berge
S. Brune-Ingebretse
F. Ivaldi
M. Cellerino
M. Pardini
G. Vila
I. Pulido-Valdeolivas
E.H. Martinez-Lapiscina
S. Llufriu
A. Saiz
Y. Blanco
E. Martinez-Heras
E. Solana
P. Bäcker-Koduah
J. Behrens
J. Kuchling
S. Asseyer
M. Scheel
C. Chien
H. Zimmermann
S. Motamedi
J. Kauer-Bonin
A. Brandt
J. Saez-Rodriguez
L.G. Alexopoulos
F. Paul
H.F. Harbo
H. Shams
J. Oksenberg
A. Uccelli
R. Baeza-Yates
P. Villoslada

Preferences, adherence, and satisfaction: three years of treatment experiences of people with multiple sclerosis

O. Hoffmann
F. Paul
R. Haase
R. Kern
T. Ziemssen